Abbott redeems $1.3 billion portion of 2.35% notes due 2019

By Wendy Van Sickle

Columbus, Ohio, June 22 – Abbott Laboratories redeemed $1.3 billion of its $1,795,500,000 of outstanding 2.35% notes due 2019 on Friday, according to an 8-K filing with the Securities and Exchange Commission.

The notes were redeemed at 102.645 plus accrued interest to but excluding the redemption date.

Following the partial redemption, $495.5 million of the 2.35% notes remain outstanding.

Abbott is a pharmaceutical health-care products company based in Abbott Park, Ill.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.